082850 — Wooree Bio Co Cashflow Statement
0.000.00%
- KR₩97bn
- KR₩160bn
- KR₩1tn
Annual cashflow statement for Wooree Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 16,983 | 44,041 | 25,126 | 18,946 | 8,227 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 29,754 | 13,323 | 20,231 | 7,337 | 16,205 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -19,164 | -42,713 | -38,198 | -31,619 | -15,723 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 66,418 | 50,208 | 43,353 | 26,515 | 36,240 |
| Capital Expenditures | -18,110 | -12,766 | -13,425 | -11,065 | -83,567 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 6,709 | -5,051 | -29,028 | 5,567 | 29,509 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11,400 | -17,816 | -42,453 | -5,498 | -54,058 |
| Financing Cash Flow Items | -357 | -49.2 | 9.74 | 540 | -1,603 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -35,939 | -3,571 | -21,282 | -29,349 | 26,709 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19,078 | 30,240 | -19,781 | -5,871 | 9,268 |